Web Analytics




Home Tags Posts tagged with "Pharmaceutical Industry"

Tag: Pharmaceutical Industry

Sun Pharma Organon Acquisition
Deal digest

Firms map out Sun Pharma’s USD11.75bn Organon acquisition

Firms guide Sun Pharmaceutical Industries, its subsidiaries and associate companies on the USD11.75 billion Organon acquisition

0
China Antitrust Law Regime
Practice Guides

Unpacking China’s antitrust law regime

By Han Ye, Lushen Hong and Xiao Fu, Merits & Tree

China tightens antitrust rules with AML reforms and stricter enforcement

0
Healthtech Regulations
Practice Guides

A comparison of developments in healthtech

South Korea boosts drug development; Russia tackles telemedicine and data protection

0
South Korea Healthcare Pharma
Practice Guides

Healthcare update in South Korea

By Sung-Tae Kim, Hyun Wook Kim, Youngsik Byun and Minyoung Park, Shin & Kim
0
Won-Young-Jung
In-house agenda

IHCF appoints new leader in Seoul

IHCF names Australian lawyer with 16 years in global pharma as new president

0
Biosecure Act Impact
Practitioners' perspectives

Confronting biopharma sanctions from US Biosecure Act

By Zhang He, Tiantai Law Firm
0
BJContinent-achieves-first-reverse-US-takeover-under-new-rules
Deal Highlights

BJContinent achieves first reverse US takeover under new rules

Gibson Dunn, Orrick, and DeHeng facilitate BJContinent's historic reverse US takeover under new rule

0
How to amicably terminate a pharmaceutical BD project
Practitioners' perspectives

How to amicably terminate a pharmaceutical BD project

By Aaron Gu and Zhu Min, Han Kun Law Offices
0
A photo of Xia Yibin
AnJie Broad Law Firm

Public scrutiny of unfair competition in the pharmaceutical industry

By Xia Yibin, AnJie Law Firm
0
Cindy Hu, Concord & Partners, Foreign investment in pharmaceutical companies, 外资并购境内医药企业
Concord & Partners

Foreign investment in pharmaceutical companies

By Cindy Hu, Concord & Partners
0
Abhai Pandey,Lawyer,Lex Orbis IP Practice
LexOrbis

Addressing the need to centrally regulate pharma

By Abhai Pandey,Lex Orbis IP Practice
0

LATEST ON LAW.ASIA

Sambu Corporate Rehabilitation

PDLegal adds ex-public prosecutor as counsel in Thailand

Pune Legal Market Guide

Experts share insights on why Pune is the right destination for establishing or expanding your business, and on the finer details of setting up

Mitsubishi USD1 Billion Senior Notes Offering

Firms advise on Mitsubishi’s USD1bn senior notes offering

Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
India GCC compliance frameworkvideo

Setting up a GCC in India

By Vikas Agarwal and Vivek Sadhale, LegaLogic Consulting

MOST READ ON LAW.ASIA

Correspondents

Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Arbitration Due Process Limitsvideo

Policy, process and delay in arbitral challenges

By Sneha Jaisingh and Jaidhara Shah, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Archive Archive Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now